Anti-Coa implicated in severe haemolytic disease of the foetus and newborn

Transfusion Medicine

Volumn 18, Issue 1, 2008, Pages 71-73

  Michalewska, B ^a   Wielgos, M ^b   Zupanska, B ^a   Bartkowiak, R ^b  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Anti Coa alloantibodies; Haemolytic disease of the foetus newborn; Intrauterine and exchange transfusion

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; BILIRUBIN; COLTON ANTIBODY; COLTON ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION REACTION; CASE REPORT; CAUCASIAN; CHEMOLUMINESCENCE; DOPPLER FLOWMETRY; EXCHANGE BLOOD TRANSFUSION; FETUS HYDROPS; FOLLOW UP; HUMAN; INCIDENCE; INTRAUTERINE BLOOD TRANSFUSION; NEWBORN; NEWBORN HEMOLYTIC DISEASE;

AQUAPORIN 1; BLOOD GROUP ANTIGENS; BLOOD TRANSFUSION, INTRAUTERINE; ERYTHROCYTE TRANSFUSION; FEMALE; GESTATIONAL AGE; HUMANS; HYDROPS FETALIS; ISOANTIBODIES; PREGNANCY;

EID: 39049161066     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2007.00799.x     Document Type: Article

References (9)

1. a. Immunohematology, 17, 45 49.
2. Daniels, G 2002) Human Blood Groups (2nd edn). Blackwell Science, Oxford.
3. Hadley, A.G., Wilkes, A., Goodrick, J., Penman, D., Soothill, P. Lucas, G 1998) The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn. British Journal of Obstetrics and Gynaecology, 105, 231 234.
4. a. Vox Sanguinis, 12, 18 24.
5. a implicated in delay hemolytic transfusion reaction. Transfusion, 22, 407 (Abstract).
6. a implicated in hemolytic disease of the newborn. Transfusion, 16, 76 78.
7. a and severe haemolytic disease of the newborn. South African Medical Journal, 47, 1302 1304.
8. a found in pregnancy Vox Sanguinis, 18, 62 66.
9. Zupanska, B., Lenkiewicz, B., Michalewska, B. Rokicki, T 2001) The ability of cellular assay to predict the necessity for cordocenteses in pregnancies at risk of haemolytic disease of the newborn. Vox Sanguinis, 80, 234 235.